Fluorodeoxyglucose F18 FDA Link

The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)

Also Known As:

Fludeoxyglucose F 18; 18F-FDG; Fluorine-18-fluorodeoxyglucose; Fluorodeoxyglucose F 18; 2 Fluoro 2 deoxy D glucose; 2 Fluoro 2 deoxyglucose; F 18, Fludeoxyglucose; F 18, Fluorodeoxyglucose; F18, Fluorodeoxyglucose; Fluorine 18 fluorodeoxyglucose; Fluorodeoxyglucose, 18F; 18F Fluorodeoxyglucose; 18FDG; 2-Fluoro-2-deoxy-D-glucose; 2-Fluoro-2-deoxyglucose

Pharmalogical Action Categories:

Radiopharmaceuticals

Carbohydrates: 22516
- Deoxy Sugars: 6
  - Deoxyglucose: 2933
    - Fluorodeoxyglucose F18: 10921

SNAP (CSP 027) Study Group Selected Research

SNAP (CSP 027) Study Group Research Topics

Disease

Drug/Important Bio-Agent (IBA)